Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]

Known as: FONDAPARINUX SODIUM 7.5 mg in 0.6 mL SUBCUTANEOUS INJECTION, SOLUTION [ARIXTRA], 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe, Arixtra 7.5 MG in 0.6 ML Prefilled Syringe 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Glycosaminoglycans (GAGs) are carbohydrate polyionic polymers that participate in a host of critically important biological… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
2015
2015
We validate the utility of ion mobility to measure protein conformational changes induced by the binding of glycosaminoglycan… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
Recently, experimental conditions were presented for the detection of the N-sulfoglucosamine (GlcNS) NHSO(3)(-) or sulfamate (1)H… Expand
2012
2012
SummaryAbstractFondaparinux sodium (Arixtra®; fondaparinux) is the first of a new class of synthetic pentasaccharide… Expand
  • figure 1
  • table I
  • table II
  • table III
  • table IV
2009
2009
In the present article we describe the gas-phase dissociation behavior of the dimeric form of monocyte chemoattractant protein-1… Expand
2004
2004
Auteur(s) :, Roger Cariou* Departement therapeutique thrombose, Sanofi Synthelabo Recherche, 91385 Chilly Mazarin cedex, France… Expand
2004
2004
Background: The MATISSE trials showed that a single dose regimen of fondaparinux, a synthetic selective factor Xa inhibitor, was… Expand
2002
2002
  • P. Giangrande
  • The Medical letter on drugs and therapeutics
  • 2002
  • Corpus ID: 2714295
Fondaparinux is a promising new antithrombotic agent. This pentasaccharide selectively and specifically inhibits coagulation… Expand
2002
2002
Fondaparinux (Arixtra®; Sanofi-Synthélabo/Organon) is the first of a new class of antithrombotic agents distinct from low… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3